The expansion of these cells ex-vivo (outside the body) would allow advances in bone marrow transplantation, in which HSCs are transferred to a patient to re-establish blood formation.
A expansión destas células ex-vivo (fóra do corpo) podería ser un avance no transplante de medula ósea, no cal as HSC se transfiren a un paciente para restablecer a formación de sangue.